
P/E Ratio: Price to Earnings - Most used valuation metric
Analyzing Investment Quality
Processing 9 key metrics...
Loading shareholding data...
No insider trading data available
Standard pivot points - most widely used
| Level | Price | Distance | % Change |
|---|---|---|---|
| R4 | ₹2751.67 | +₹601.47 | +27.97% |
| R3 | ₹2521.77 | +₹371.57 | +17.28% |
| R2 | ₹2433.53 | +₹283.33 | +13.18% |
| R1 | ₹2291.87 | +₹141.67 | +6.59% |
| PIVOT | ₹2203.63 | 53.43 | 2.49% |
| CURRENT | ₹2150.20 | - | - |
| S1 | ₹1602.17 | -₹548.03 | -25.49% |
| S2 | ₹1832.07 | -₹318.13 | -14.80% |
| S3 | ₹1973.73 | -₹176.47 | -8.21% |
| S4 | ₹2061.97 | -₹88.23 | -4.10% |
is trading CPR, indicating
CPR is
Day's range: ~
Trading Inside opening range
| Company Name |
|---|
Amrutanjan Health Care Ltd |
Anuh Pharma Ltd |
Bajaj Healthcare Ltd |
Beta Drugs Ltd |
Bliss GVS Pharma Ltd |
Indoco Remedies Ltd |
Ind-Swift Laboratories Ltd |
Jagsonpal Pharmaceuticals Ltd |
Kopran Ltd |
Lincoln Pharmaceuticals Ltd |
Morepen Laboratories Ltd |
Sakar Healthcare Ltd |
Sigachi Industries Ltd |
Sun Pharmaceutical Industries Ltd |
Syncom Formulations (India) Ltd |
Themis Medicare Ltd |
TTK Healthcare Ltd |
Venus Remedies Ltd |
Wanbury Ltd |

301, E Square,, Subhash Road,, Vile Parle East.
Mumbai
MAHARASHTRA
IN
Tel: 912240842222
Website:https://www.nglfinechem.com/
Group: Pharmaceuticals, Biotechnology & Life Sciences
Sector: Health Care
Industry: Pharmaceuticals
Exchange: NATIONAL STOCK EXCHANGE OF INDIA
Employees: 682
IPO Date: 20/12/1994
Mr. Rajesh Lawande
Chief Financial Officer, Whole Time Director
Mrs. Pallavi Pednekar
Compliance Officer, Company Secretary
Mr. Rahul Nachane
Managing Director, Director
Mr. Dhananjay Mungale
Additional Non-Executive Director
Ms. Ajita Nachane
Non-Executive Director
Mr. Sudhir Deo
Additional Non-Executive Independent Director
Ms. Sarala Menon
Non-Executive Woman Independent Director
Mr. Jayaram Sitaram
Non-Executive Independent Director
Get answers to the most common questions about NGL Fine Chem Ltd stock price, fundamentals, financial metrics, and investment analysis